US Bancorp’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
22,173
+20,302
| +1,085% | +$103K | ﹤0.01% | 2368 |
|
|
2025
Q1 | $9.9K | Buy |
1,871
+163
| +10% | +$862 | ﹤0.01% | 3425 |
|
|
2024
Q4 | $11.5K | Sell |
1,708
-455
| -21% | -$3.08K | ﹤0.01% | 3348 |
|
|
2024
Q3 | $14.3K | Buy |
2,163
+1,453
| +205% | +$9.58K | ﹤0.01% | 3230 |
|
|
2024
Q2 | $5.33K | Buy |
710
+45
| +7% | +$338 | ﹤0.01% | 3475 |
|
|
2024
Q1 | $6.63K | Buy |
+665
| New | +$6.63K | ﹤0.01% | 3444 |
|
|
2023
Q3 | – | Sell |
-115
| Closed | -$859 | – | 4049 |
|
|
2023
Q2 | $859 | Buy |
+115
| New | +$859 | ﹤0.01% | 3790 |
|
|
2022
Q4 | – | Sell |
-16,200
| Closed | -$172K | – | 4240 |
|
|
2022
Q3 | $172K | Hold |
16,200
| – | – | ﹤0.01% | 1925 |
|
|
2022
Q2 | $132K | Buy |
+16,200
| New | +$132K | ﹤0.01% | 2083 |
|